Sign inJoin waitlistJoin the waitlist

Philip Leese

Research Assistant Professor, Psychiatry and Behavioral Sciences · University of Kansas School of Medicine

Credentials: · ·

History

University of Kansas School of Medicine
Present

Research

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
Journal of Bone and Mineral Research · 2004 · 567 citations
The effect of a single dose of osteoprotegerin in postmenopausal women
Journal of Bone and Mineral Research · 2001 · 360 citations
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial
The Journal of Clinical Pharmacology · 2000 · First of 6 authors · 293 citations

AD
Alex Depaoli
2 papers
DH
David Hoelscher
2 papers
ML
Mark Leibowitz
2 papers
RN
Robert Noveck
2 papers
SQ
Steven Quay
2 papers
Tom Callaghan
2 papers
AD
Alan Dunton
1 paper
AH
Allen Heller
1 paper
CF
Constantine Falliers
1 paper
EL
Eleanor Lisbon
1 paper
EM
Elissa Malkin
1 paper
Emanuel Kanal
1 paper

Clinical trials

Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Principal investigator · Terminated · Phase 1
Marval Pharma Ltd.
2014
A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers
Principal investigator · Completed · Phase 1
Tioga Pharmaceuticals
2011
This Study Will Assess the Safety and Tolerability of AZD8418 After Single Increasing Oral Doses
Principal investigator · Terminated · Phase 1
AstraZeneca
2009–2010
ALK33-001: A Study of RDC-0313 Administered to Healthy Adults
Principal investigator · Completed · Phase 1
Alkermes, Inc.
2008–2009